In other tumor types, including esophageal squamous cell carcinoma [31], gastric carcinoma [71], acute lymphoblastic leukemia (ALL) [72] and HPV-unrelated head and neck carcinoma [73], SMYD2 overexpression was associated with disease aggressiveness and worse outcome. This evidence concerns the gene SMYD2 and head and neck carcinoma.